AVP and Polyuria: Copeptin is now recognized as an important biomarker in the differential diagnosis of arginine vasopressin disorders, particularly in distinguishing between arginine vasopressin deficiency and resistance, as well as primary polydipsia-related polyuria-polydipsia syndromes.